Takeda to strengthen health system for rare diseases in India
These initiatives aim to improve access to healthcare for rare disease patients
These initiatives aim to improve access to healthcare for rare disease patients
CINRYZE is plasma-derived C1-I NH approved for routine prevention (prophylaxis), short-term prevention or pre-procedure prevention, and acute attacks of HAE.
Subscribe To Our Newsletter & Stay Updated